RecruitingPhase 3NCT07611110
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Sponsor: AstraZeneca
Dothan, AL · +27 more sites
Clinical trials in Dothan, AL
22 recruiting studies have a site in or near Dothan, AL, Alabama.
Top conditions here
- Crohn's Disease (8)
- Obesity (4)
- Ulcerative Colitis (3)
- Schizophrenia (3)
- Lung Cancer (2)
- Prostate Cancer (2)
- Type 2 Diabetes (2)
- Breast Cancer (1)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 22 of 22 studies
RecruitingPhase 3NCT06819878
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Hoffmann-La Roche
Dothan, AL · +94 more sites
RecruitingPhase 3NCT07424404
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Dothan, AL · +55 more sites
RecruitingPhase 2NCT07697456
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Sponsor: AbbVie
Dothan, AL · +59 more sites
RecruitingPhase 3NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Sponsor: Merck Sharp & Dohme LLC
Dothan, AL · +86 more sites
RecruitingPhase 3NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Sponsor: AstraZeneca
Birmingham, AL · Dothan, AL · +54 more sites
RecruitingPhase 3NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Sponsor: Eli Lilly and Company
Dothan, AL · +36 more sites
RecruitingPhase 3NCT06937099
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Sponsor: Eli Lilly and Company
Dothan, AL · +34 more sites
RecruitingPhase 4NCT05648591
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Sponsor: Vanda Pharmaceuticals
Dothan, AL · +10 more sites
RecruitingPhase 1 / Phase 2NCT07189871
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Sponsor: Radiopharm Theranostics, Ltd
Dothan, AL · +4 more sites
RecruitingPhase 3NCT06819891
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Hoffmann-La Roche
Dothan, AL · +60 more sites
RecruitingPhase 2NCT06548542
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Sponsor: AbbVie
Dothan, AL · Mobile, AL · +62 more sites
RecruitingPhase 3NCT07499232
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Janssen Research & Development, LLC
Dothan, AL · Mobile, AL · +37 more sites
RecruitingPhase 4NCT06095128
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Sponsor: Takeda
Dothan, AL · +36 more sites
RecruitingPhase 3NCT07037459
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Sponsor: Amgen
Birmingham, AL · Dothan, AL · Fairhope, AL · +118 more sites
RecruitingPhase 4NCT06045754
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Sponsor: Takeda
Dothan, AL · +40 more sites
RecruitingPhase 2 / Phase 3NCT07363694
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Sponsor: Pfizer
Birmingham, AL · Dothan, AL · Mobile, AL · +58 more sites
RecruitingPhase 3NCT07784725
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Dothan, AL · Huntsville, AL · +31 more sites
RecruitingPhase 3NCT05303064
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Sponsor: Alkermes, Inc.
Dothan, AL · +25 more sites
RecruitingPhase 2NCT07553637
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
Sponsor: Alto Neuroscience
Birmingham, AL · Dothan, AL · +36 more sites
RecruitingPhase 3NCT07495852
Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Sponsor: Glaukos Corporation
Dothan, AL
RecruitingPhase 1 / Phase 2NCT06228326
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
Sponsor: Krystal Biotech, Inc.
Dothan, AL · +13 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.